Clinically adoption of MSK-IMPACT, a hybridization capture-based next generation sequencing assay, for the assessment of lung adenocarcinomas Meeting Abstract
| Authors: | Arcila, M. E.; Zehir, A.; Yu, H.; Drilon, A.; Li, B. T.; Riely, G. J.; Rekhtman, N.; Lin, O.; Hyman, D.; Berger, M.; Rudin, C. M.; Kris, M. G.; Ladanyi, M. |
| Abstract Title: | Clinically adoption of MSK-IMPACT, a hybridization capture-based next generation sequencing assay, for the assessment of lung adenocarcinomas |
| Meeting Title: | 16th World Conference on Lung Cancer (WCLC) |
| Keywords: | lung adenocarcinoma; molecular profiling; targeted therapeutics; next; generation sequencing |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 10 |
| Issue: | 9 Suppl. 2 |
| Meeting Dates: | 2015 Sep 6-9 |
| Meeting Location: | Denver, CO |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2015-09-01 |
| Start Page: | S341 |
| End Page: | S342 |
| Language: | English |
| ACCESSION: | WOS:000370365101241 |
| PROVIDER: | wos |
| PUBMED: | 26710300 |
| DOI: | 10.1016/S1556-0864(16)30011-9 |
| Notes: | Meeting Abstract: MINI22.02 -- Source: Wos |
